Barry E. Greene, President and CEO at Sage Therapeutics, Inc. (SAGE), bought 23,640 shares at $43.15 ($1.0M) on 2021-08-05, disclosed to the SEC on 2021-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |
| ALNY | SELL | 2020-05-07 | $6.7M | — | Filing → |